DeFi Nirogacestat for Poor Prognosis
DeFi: Subgroup Analysis of Nirogacestat Efficacy in Patients With Desmoid Tumors and Poor Prognostic Factors

Released: December 04, 2024

Expiration: December 03, 2025

Activity

Progress
1
Course Completed